Hydroxychloroquine Drug Market
Global Hydroxychloroquine Drug Market Size, Share & Trends Analysis Report By Application Type (Covid-19, Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Others (Porphyria Cutanea Tarda (PCT) and Q Fever) , and By Dosage Type (100mg, 200mg, 400mg, 600mg, and 800mg) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global hydroxychloroquine drug market is anticipated to grow at a significant CAGR of 5.7% during the forecast period. An increasing number of malaria cases leading to the production of more medicine across the globe is acting as an important factor driving the growth of the market. For instance, as per the information provided by World Health Organization (WHO) in 2020, there were an estimated 241 million cases of malaria globally and among which the estimated number of malaria deaths account for around 627000 in 2020. So, the utilizing of hydroxychloroquine drugs in the form of tablets and vials supports in reducing the death rate.
Moreover, the growing demand for novel hydroxychloroquine and the rising penetration of generic drugs are also contributing significantly towards the growth of the market. However, the market growth for hydroxychloroquine is anticipated to be hampered by the ambiguity of long-term consequences along with other side effects including cardiac problems, diarrhea, and stomach aches that could be observed in the patients. Additionally, FDA had cautioned against the use of hydroxychloroquine for COVID-19 outside of the hospital setting or a clinical trial due to the risk of heart rhythm problems.
Impact of COVID-19 Pandemic on Global Hydroxychloroquine Drug Market
The adoption of hydroxychloroquine medications is anticipated to grow as patient awareness of COVID-19 grows and as new generics enter the market however after the trials done by the FDA (Food and Drugs Administration of U.S.) shows the negative effect on the heart by hydroxychloroquine drug. With the increasing innovations and knowledge of disease remittance therapies, clinical research on the efficacy of hydroxychloroquine is expected to boost.
Segmental Outlook
The hydroxychloroquine drug market is segmented based on the application and dosage type. Based on the application, the market is segmented into Covid-19, Malaria, Rheumatoid Arthritis, Lupus Erythematosus and others (Porphyria Cutanea Tarda (PCT) and Q Fever). Based on the Dosage type, the market is sub-segmented into the 100mg, 200mg, 400mg, 600mg, and 800mg. Among these, malaria segment in which hydroxychloroquine is mostly used, and the growth also depends on the application of the drug in African countries to the maximum level.
Global Hydroxychloroquine Drug Market Share by Application, 2021 (%)
The Rheumatoid Arthritis Segment is anticipated to lead the growth of the Global Hydroxychloroquine Drug Market
The expansion of the hydroxychloroquine market has been aided by rising cases of contagious diseases such as malaria along with its increased R&D. Furthermore, developments in treatment options and the presence of well-established healthcare facilities are some of the determinants of demand for hydroxychloroquine medications. Drug discontinuance and product recall, on the other hand, are issues that can stymie market growth. Hydroxychloroquine is a chloroquine analog and medicine. It possesses both antimalarial and antirheumatic properties. It's also commonly utilized in the treatment of rheumatoid arthritis. Throughout the projected period, rheumatoid arthritis is expected to dominate the worldwide hydroxychloroquine medicines market. This is due to an increase in the prevalence of rheumatoid arthritis, which produces a variety of symptoms including joint pain, swelling, and stiffness, as well as persistent discomfort and the inability to conduct daily activities. This illness can limit a patient's movement and lead to permanent joint damage if left untreated. If left untreated, this condition can impede mobility and put you at risk for joint replacement.
Regional Outlooks
The global hydroxychloroquine market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). North American region will be a prominent regional market over the forecast period owing to factors such as a sizeable population of Lupus patients. Besides, US is contributing immensely to the growth in the market by way of government endorsements; a large number of clinical trials are underway.
Global Hydroxychloroquine Drug Market Growth, by Region 2022-2028
The Asia-Pacific region is estimated to hold the Major Share in the Hydroxychloroquine Drug Market
The Asia-Pacific region's dominance can be ascribed to the presence of key market participants such as India and China in the region, as well as a surge in demand for the drug due to high malaria prevalence rates in Southeast Asian countries. For instance, In December 2020, Lonza has stated that they have expanded their relationship with Aurinia Pharmaceuticals in order to increase manufacturing capacity for efficient Voclosporin production.
Market Players Outlook
The major companies serving the hydroxychloroquine drug market include Cipla Ltd, Sanofi S.A., Ipca Laboratories Ltd., Novartis International AG, Teva Pharmaceutical Industries Ltd, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2020Teva donated 6 million doses of hydroxychloroquine sulfate tablets to the hospitals around the globe.
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global hydroxychloroquine market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Hydroxychloroquine Drug Market
• Recovery Scenario of Global Hydroxychloroquine Drug Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Cipla Ltd
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Sanofi S.A.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Ipca Laboratories Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Novartis International AG
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Teva Pharmaceutical Industries Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Hydroxychloroquine Market by Application
4.1.1. COVID-19
4.1.2. Malaria
4.1.3. Rheumatoid Arthritis
4.1.4. Lupus Erythematosus
4.1.5. Others (Porphyria cutanea tarda (PCT) and Q Fever)
4.2. Global Hydroxychloroquine Market by Dosage Type
4.2.1. 100 mg
4.2.2. 200 mg
4.2.3. 400 mg
4.2.4. 600 mg
4.2.5. 800 mg
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott Healthcare Pvt. Ltd
6.2. Advanz Pharma Corp.
6.3. Agio Pharmaceuticals Ltd.
6.4. Amneal Pharmaceuticals, Inc.
6.5. Apotex Inc.
6.6. Bayer AG
6.7. Bristol Laboratories Ltd.
6.8. Cadila Healthcare Ltd. (CHL)
6.9. Cardinal Health, Inc.
6.10. Chemo Biological Ltd.
6.11. Covis Pharmaceuticals, Inc.
6.12. Dr. Reddy's Laboratories Ltd.
6.13. Fdc Ltd.
6.14. Intas Pharmaceuticals Ltd.
6.15. Kopran Ltd.
6.16. Laurus Labs Ltd.
6.17. Lupin Ltd.
6.18. Mangalam Drugs and Organics Ltd.
6.19. Mylan N.V.
6.20. Shenhua Pharmaceutical Co., Ltd.
6.21. Snehal Pharma & Surgical Pvt. Ltd.
6.22. Sun Pharmaceutical Industries Ltd.
6.23. Torrent Pharmaceuticals Ltd.
6.24. Wallace Pharmaceuticals Ltd.
6.25. Zaneka Healthcare Pvt. Ltd.
1. GLOBAL HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
2. GLOBAL COVID-19 HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL MALARIA HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL RHEUMATOID ARTHRITIS HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL LUPUS ERYTHEMATOSUS HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL OTHERS (PORPHYRIA CUTANEA TARDA (PCT) AND Q FEVER) HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
8. GLOBAL 100 MG HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL 200 MG HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL 400 MG HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL 600 MG HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL 800 MG HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. NORTH AMERICAN HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
17. EUROPEAN HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. EUROPEAN HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. EUROPEAN HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. REST OF THE WORLD HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25. REST OF THE WORLD HYDROXYCHLOROQUINE DRUG MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL HYDROXYCHLOROQUINE DRUG MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL HYDROXYCHLOROQUINE DRUG MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL HYDROXYCHLOROQUINE DRUG MARKET, 2022-2028 (%)
4. GLOBAL HYDROXYCHLOROQUINE DRUG MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
5. GLOBAL COVID-19 HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL MALARIA HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL RHEUMATOID ARTHRITIS HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL LUPUS ERYTHEMATOSUS HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OTHERS (PORPHYRIA CUTANEA TARDA (PCT) AND Q FEVER) HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL HYDROXYCHLOROQUINE DRUG MARKET SHARE BY DOSAGE TYPE, 2028 VS 2028 (%)
11. GLOBAL 100 MG HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL 200 MG HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL 400 MG HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL 600 MG HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL 800 MG HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL HYDROXYCHLOROQUINE DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. US HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
18. CANADA HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
19. UK HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
20. FRANCE HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
21. GERMANY HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
22. ITALY HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
23. SPAIN HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF EUROPE HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
25. INDIA HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
26. CHINA HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
27. JAPAN HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
28. SOUTH KOREA HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF ASIA-PACIFIC HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD HYDROXYCHLOROQUINE DRUG MARKET SIZE, 2021-2028 ($ MILLION)
